Navigation Links
Rocky Mountain Biologicals CEO Selected to Participate in the 2013 Montana Economic Development Conference in Butte
Date:9/13/2013

Missoula, Montana (PRWEB) September 13, 2013

Rocky Mountain Biologicals (RMBIO), http://www.rmbio.com, announced today that Suresh Daniel, CEO of RMBIO is scheduled to participate in the 2013 Economic Development Conference. Daniels will moderate the discussion, “Chemistry Under the BigSky: The Growth of Biochemicals in MT”. Panel members scheduled to participate include senior leaders from Blue Marble Biotechnology, River Top Renewables, Sapphire Energy and Dow.

The Economic Summit is sponsored by Senator Max Baucus and is hosted by Montana Tech in Butte. There are many keynote speakers this year including Google Executive Chairman Eric Schmidt, Facebook’s Sheryl Sandberg, Oracle’s Safra Catz, founder of FedEx Fred Smith and, Ryan Lance, CEO of ConocoPhillips.

The conference is designed to provide network and business opportunities for Montana companies. This is achieved by providing a forum for interaction and networking among some of the world’s leading companies with Montana entrepreneurs and businesses.

Daniel stated, “We appreciate the opportunity to participate in the conference, and for the opportunities to network with companies that are potential partners and investors of RMBIO. We have always found that the hardest step in acquiring a new multi-national customer is simply getting them to come and visit our facility in Missoula. Once they come, without exception, our employees, the quality of our products, and our value proposition win them over. I am sure we are no different than many Montana-based businesses in this regard. In this case, the conference has brought many businesses that we aim to partner with to our State. JJ Adams and the entire staff of Senator Baucus deserve a lot of credit for bringing such a high quality event to Montana.”

Current and prospective customers of RMBIO including Amgen, Johnson & Johnson Development Corporation, Merck, and Pfizer are all attendees and sponsors of the conference.

RMBIO is a manufacturer of bovine, porcine, equine and other custom protein products used in the Life Sciences industry. The company uses proprietary processing technology to fractionate animal blood into the growth factors required to make cell culture media. RMBIO was founded in 2004 and operates a 20,000 square foot state-of-the-art production facility in Missoula, Montana.

Daniels and the panel will be presenting on Monday, September 16, 2013 in the Mining and Geology building on the campus of Montana Tech from 1-2:15. Additional information about the conference can be found at http://www.montanajobssummit.com.

Read the full story at http://www.prweb.com/releases/rmbio/baucussummit/prweb11115022.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. EnduRx Pharmaceuticals to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
2. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
3. Rocky Mountain Biologicals Joins International Serum Industry Association
4. Newborn Calf Serum Added to Growing Product Suite of Rocky Mountain Biologicals
5. Rocky Mountain Biologicals Expands Custom Serum Filtration Facility
6. White Mountain Process' New Whisper Technology Creates World's Only Squeal-less Mechanical Seal
7. San Antonio Investigators Report on Mountain Cedar Allergy Model
8. Medical Manufacturing to Mountaineering: KMC Employees Take it to the Top
9. White Mountain Process Announces Sanitary Autoclave Style Pharmaceutical Agitator
10. Tote Mixers In 48 Hours From White Mountain Process Mixers, Agitators & Blenders
11. White Mountain Process Introduces Squeal-less Mechanical Seal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):